Olmesartan medoxomil and Losartan potassium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Olmesartan medoxomil (olmesartan medoxomil) and Losartan potassium (losartan potassium). Common drug interactions include haematochezia among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Olmesartan medoxomil and Losartan potassium. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Olmesartan medoxomil?

Olmesartan medoxomil has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 15,240 Olmesartan medoxomil users. Check the latest studies of Olmesartan medoxomil.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.



On Jul, 17, 2026

96 people who take Olmesartan medoxomil and Losartan potassium together, and have interactions are studied.

Olmesartan medoxomil and Losartan potassium drug interactions.

What are the common drug interactions of Olmesartan Medoxomil and Losartan Potassium, by gender? *:

female:

  1. Haematochezia (passage of stools containing blood)
  2. Osteonecrosis (death of bone)
  3. Renal impairment (severely reduced kidney function)
  4. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  5. Skin ulcer
  6. Viral infection
  7. Cough
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Neuropathy peripheral (surface nerve damage)
  10. Asthenia (weakness)

male:

  1. Dizziness
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Headache (pain in head)
  4. Infusion related reaction
  5. Nausea (feeling of having an urge to vomit)
  6. Back pain
  7. Cardiac disorder
  8. Depressed mood
  9. Parathyroid tumour
  10. Sinusitis (inflammation of sinus)

What are the common drug interactions of Olmesartan Medoxomil and Losartan Potassium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Abdominal pain
  3. Bacteriuria (presence of bacteria in urine)
  4. Blood glucose increased
  5. Cardiovascular disorder (heart diseases)
  6. Constipation
  7. Dehydration (dryness resulting from the removal of water)
  8. Diabetes mellitus inadequate control
  9. Drug level above therapeutic
  10. Dry skin

30-39:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Dizziness
  6. Glaucoma (increased fluid pressure in the eye with vision loss)
  7. Neuropathy peripheral (surface nerve damage)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Purpura senile (skin condition in which areas of the skin develop a purplish or reddish-brown appearance due to bleeding of small blood vessels underneath)
  10. Renal failure (kidney dysfunction)

40-49:

  1. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  2. Gastroenteritis (inflammation of stomach and intestine)
  3. Haematochezia (passage of stools containing blood)
  4. Osteonecrosis (death of bone)
  5. Pain
  6. Renal impairment (severely reduced kidney function)
  7. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  8. Skin ulcer
  9. Viral infection
  10. Emotional disorder

50-59:

  1. Back pain
  2. Cardiac disorder
  3. Depressed mood
  4. Headache (pain in head)
  5. Pain
  6. Parathyroid tumour
  7. Sinusitis (inflammation of sinus)
  8. Adverse event
  9. Nasopharyngitis (inflammation of the nasopharynx)
  10. Altered state of consciousness (altered state of mind)

60+:

  1. Dizziness
  2. Confusional state
  3. Nasal polyps (masses that develop in the lining of the nose)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Vertigo
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Bladder cancer
  9. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  10. Infusion related reaction

What are the existing conditions these people have? *

  1. Pain: 11 people, 11.46%
  2. Breast Cancer Metastatic: 8 people, 8.33%
  3. Nausea (feeling of having an urge to vomit): 6 people, 6.25%
  4. Hypersensitivity: 6 people, 6.25%
  5. Depression: 6 people, 6.25%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 5.21%
  7. Constipation: 5 people, 5.21%

* Approximation only. Some reports may have incomplete information.

Do you take Olmesartan medoxomil and Losartan potassium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Olmesartan medoxomil and Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Olmesartan medoxomil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Olmesartan medoxomil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Losartan potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on olmesartan medoxomil and losartan potassium (the active ingredients of Olmesartan medoxomil and Losartan potassium, respectively), and Olmesartan medoxomil and Losartan potassium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: